Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

mTORC2 Activity Disrupts Lysosome Acidification in Systemic Lupus Erythematosus by Impairing Caspase-1 Cleavage of Rab39a.

Monteith AJ, Vincent HA, Kang S, Li P, Claiborne TM, Rajfur Z, Jacobson K, Moorman NJ, Vilen BJ.

J Immunol. 2018 Jul 15;201(2):371-382. doi: 10.4049/jimmunol.1701712. Epub 2018 Jun 4.

2.

BAFF Induces Tertiary Lymphoid Structures and Positions T Cells within the Glomeruli during Lupus Nephritis.

Kang S, Fedoriw Y, Brenneman EK, Truong YK, Kikly K, Vilen BJ.

J Immunol. 2017 Apr 1;198(7):2602-2611. doi: 10.4049/jimmunol.1600281. Epub 2017 Feb 24.

3.

Staphylococcus aureus Protein A Disrupts Immunity Mediated by Long-Lived Plasma Cells.

Keener AB, Thurlow LT, Kang S, Spidale NA, Clarke SH, Cunnion KM, Tisch R, Richardson AR, Vilen BJ.

J Immunol. 2017 Feb 1;198(3):1263-1273. doi: 10.4049/jimmunol.1600093. Epub 2016 Dec 28.

4.

Immune cells and type 1 IFN in urine of SLE patients correlate with immunopathology in the kidney.

Scott E, Dooley MA, Vilen BJ, Clarke SH.

Clin Immunol. 2016 Jul;168:16-24. doi: 10.1016/j.clim.2016.04.005. Epub 2016 Apr 18.

PMID:
27102764
5.

Apoptotic Debris Accumulates on Hematopoietic Cells and Promotes Disease in Murine and Human Systemic Lupus Erythematosus.

Kang S, Rogers JL, Monteith AJ, Jiang C, Schmitz J, Clarke SH, Tarrant TK, Truong YK, Diaz M, Fedoriw Y, Vilen BJ.

J Immunol. 2016 May 15;196(10):4030-9. doi: 10.4049/jimmunol.1500418. Epub 2016 Apr 8.

6.

Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus.

Monteith AJ, Kang S, Scott E, Hillman K, Rajfur Z, Jacobson K, Costello MJ, Vilen BJ.

Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):E2142-51. doi: 10.1073/pnas.1513943113. Epub 2016 Mar 28.

7.

IgG-Immune Complexes Promote B Cell Memory by Inducing BAFF.

Kang S, Keener AB, Jones SZ, Benschop RJ, Caro-Maldonado A, Rathmell JC, Clarke SH, Matsushima GK, Whitmire JK, Vilen BJ.

J Immunol. 2016 Jan 1;196(1):196-206. doi: 10.4049/jimmunol.1402527. Epub 2015 Nov 30.

8.

Receptor cross-talk spatially restricts p-ERK during TLR4 stimulation of autoreactive B cells.

Lee SR, Rutan JA, Monteith AJ, Jones SZ, Kang SA, Krum KN, Kilmon MA, Roques JR, Wagner NJ, Clarke SH, Vilen BJ.

J Immunol. 2012 Oct 15;189(8):3859-68. doi: 10.4049/jimmunol.1200940. Epub 2012 Sep 14.

9.

Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages.

Gilbert MR, Wagner NJ, Jones SZ, Wisz AB, Roques JR, Krum KN, Lee SR, Nickeleit V, Hulbert C, Thomas JW, Gauld SB, Vilen BJ.

J Immunol. 2012 Jul 15;189(2):711-20. doi: 10.4049/jimmunol.1102973. Epub 2012 Jun 6.

10.

Increased hematopoietic cells in the mertk-/- mouse peritoneal cavity: a result of augmented migration.

Williams JC, Wagner NJ, Earp HS, Vilen BJ, Matsushima GK.

J Immunol. 2010 Jun 15;184(12):6637-48. doi: 10.4049/jimmunol.0902784. Epub 2010 May 14.

11.

The receptor tyrosine kinase MerTK regulates dendritic cell production of BAFF.

Gohlke PR, Williams JC, Vilen BJ, Dillon SR, Tisch R, Matsushima GK.

Autoimmunity. 2009 Mar;42(3):183-97. doi: 10.1080/08916930802668586.

12.

The regulation of autoreactive B cells during innate immune responses.

Vilen BJ, Rutan JA.

Immunol Res. 2008;41(3):295-309. doi: 10.1007/s12026-008-8039-8.

13.
14.

Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6.

Kilmon MA, Wagner NJ, Garland AL, Lin L, Aviszus K, Wysocki LJ, Vilen BJ.

Blood. 2007 Sep 1;110(5):1595-602. Erratum in: Blood. 2008 Mar 15;111(6):3299.

15.

B-cell anergy: from transgenic models to naturally occurring anergic B cells?

Cambier JC, Gauld SB, Merrell KT, Vilen BJ.

Nat Rev Immunol. 2007 Aug;7(8):633-43. Epub 2007 Jul 20. Review.

16.

Dendritic cells from lupus-prone mice are defective in repressing immunoglobulin secretion.

Gilbert MR, Carnathan DG, Cogswell PC, Lin L, Baldwin AS Jr, Vilen BJ.

J Immunol. 2007 Apr 15;178(8):4803-10.

17.

Early preplasma cells define a tolerance checkpoint for autoreactive B cells.

Culton DA, O'Conner BP, Conway KL, Diz R, Rutan J, Vilen BJ, Clarke SH.

J Immunol. 2006 Jan 15;176(2):790-802.

18.
19.

Low-affinity, Smith antigen-specific B cells are tolerized by dendritic cells and macrophages.

Kilmon MA, Rutan JA, Clarke SH, Vilen BJ.

J Immunol. 2005 Jul 1;175(1):37-41.

20.

Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.

Kerry SE, Buslepp J, Cramer LA, Maile R, Hensley LL, Nielsen AI, Kavathas P, Vilen BJ, Collins EJ, Frelinger JA.

J Immunol. 2003 Nov 1;171(9):4493-503.

21.
22.
23.

B cell antigen receptor desensitization: disruption of receptor coupling to tyrosine kinase activation.

Vilen BJ, Famiglietti SJ, Carbone AM, Kay BK, Cambier JC.

J Immunol. 1997 Jul 1;159(1):231-43.

24.
25.

CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors.

Wright KL, Vilen BJ, Itoh-Lindstrom Y, Moore TL, Li G, Criscitiello M, Cogswell P, Clarke JB, Ting JP.

EMBO J. 1994 Sep 1;13(17):4042-53.

Supplemental Content

Loading ...
Support Center